Inventor
DOYON YANNICK
US18 patents
⚠️ This page may combine multiple inventors who share the name “DOYON YANNICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DOYON YANNICK
5 patentsUS8962281B2Feb 24, 2015
Engineered cleavage half-domains
DOYON YANNICK66 citations98
US8623618B2Jan 7, 2014
Engineered cleavage half-domains
DOYON YANNICK141 citations98
US8772008B2Jul 8, 2014
Methods and compositions for increasing nuclease activity
DOYON YANNICK19 citations92
US9506120B2Nov 29, 2016
Rapid in vivo identification of biologically active nucleases
DOYON YANNICK6 citations72
US8772009B2Jul 8, 2014
Methods and compositions for increasing nuclease activity
DOYON YANNICK3 citations62
SANGAMO THERAPEUTICS INC
5 patentsUS10640790B2May 5, 2020
Artificial nucleases including engineered FokI cleavage half-domains
SANGAMO THERAPEUTICS INC3 citations84
US10066242B2Sep 4, 2018
Artificial nucleases comprising engineered cleavage half-domains
SANGAMO THERAPEUTICS INC5 citations84
US11136599B2Oct 5, 2021
Artifical nucleases comprising engineered cleavage half-domains
SANGAMO THERAPEUTICS INC2 citations73
US11725218B2Aug 15, 2023
Artificial nucleases comprising engineered cleavage half-domains
SANGAMO THERAPEUTICS INC0 citations62
US10827731B2Nov 10, 2020
Method of inactivating the IPK1 gene in corn
SANGAMO THERAPEUTICS INC0 citations41
SANGAMO BIOSCIENCES INC
4 patentsUS9376689B2Jun 28, 2016
Engineered cleavage half-domains
SANGAMO BIOSCIENCES INC8 citations92
US9765361B2Sep 19, 2017
Engineered cleavage half-domains for generating nuclease-mediated genomic modifications in a cell
SANGAMO BIOSCIENCES INC5 citations84
US9150879B2Oct 6, 2015
Engineered cleavage half-domains
SANGAMO BIOSCIENCES INC5 citations84
US9115409B2Aug 25, 2015
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
SANGAMO BIOSCIENCES INC4 citations72